CVS Health Corp.'s Proposed Senior Unsecured Notes Rated 'BBB+' - S&P Global Ratings’ Credit Research

CVS Health Corp.'s Proposed Senior Unsecured Notes Rated 'BBB+'

CVS Health Corp.'s Proposed Senior Unsecured Notes Rated 'BBB+' - S&P Global Ratings’ Credit Research
CVS Health Corp.'s Proposed Senior Unsecured Notes Rated 'BBB+'
Published May 16, 2016
3 pages (1171 words) — Published May 16, 2016
Price US$ 150.00  |  Buy this Report Now

About This Report

  
Abstract:

NEW YORK (S&P Global Ratings) May 16, 2016--S&P Global Ratings today assigned its 'BBB+' issue-level rating to CVS Health Corp.'s proposed senior unsecured notes. The company plans to use the net proceeds from the offering for general corporate purposes including the refinancing of certain outstanding debt. CVS (BBB+/Stable/A-2) has successfully strengthened its competitive position and diversified its revenues and cash flow streams through the growth of its retail pharmacy, pharmacy benefits management services, and specialty pharmacy segments. It has a good track record of operating performance,which we expect to continue despite reimbursement rate pressures and the impact of generic drug introductions. The integration of Target pharmacies and Omnicare business it acquired in 2015 is proceeding well and the company is

  
Brief Excerpt:

...NEW YORK (S&P Global Ratings) May 16, 2016--S&P Global Ratings today assigned its '###+' issue-level rating to CVS Health Corp.'s proposed senior unsecured notes. The company plans to use the net proceeds from the offering for general corporate purposes including the refinancing of certain outstanding debt. CVS (###+/Stable/A-2) has successfully strengthened its competitive position and diversified its revenues and cash flow streams through the growth of its retail pharmacy, pharmacy benefits management services, and specialty pharmacy segments. It has a good track record of operating performance,which we expect to continue despite reimbursement rate pressures and the impact of generic drug introductions. The integration of Target pharmacies and Omnicare business it acquired in 2015 is proceeding well and the company is achieving its target cost and sourcing synergies. We believeperformance gains will help the company generate about $7.7 billion of operating cash flow and nearly $5.5 billion...

  
Report Type:

Ratings Action

Ticker
Issuer
GICS
Health Care Services (35102015)
Sector
Global Issuers , Structured Finance
Country
Region
Format:
PDF Adobe Acrobat
Buy Now

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "CVS Health Corp.'s Proposed Senior Unsecured Notes Rated 'BBB+'" May 16, 2016. Alacra Store. Nov 07, 2026. <http://www.alacrastore.com/s-and-p-credit-research/CVS-Health-Corp-s-Proposed-Senior-Unsecured-Notes-Rated-BBB-1636222>
  
APA:
S&P Global Ratings’ Credit Research. (). CVS Health Corp.'s Proposed Senior Unsecured Notes Rated 'BBB+' May 16, 2016. New York, NY: Alacra Store. Retrieved Nov 07, 2026 from <http://www.alacrastore.com/s-and-p-credit-research/CVS-Health-Corp-s-Proposed-Senior-Unsecured-Notes-Rated-BBB-1636222>
  
US$ 150.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Residential Mortgage-Backed Securities from one place.